Generic placeholder image

Current Rheumatology Reviews

Editor-in-Chief

ISSN (Print): 1573-3971
ISSN (Online): 1875-6360

Case Report

Arthroscopic Excision of a Localized Tenosynovial Giant Cell Tumor of the Knee: A Case Report

Author(s): Hassan Zmerly*, Maurizio Draghetti, Manuela Moscato and Ibrahim Akkawi

Volume 20, Issue 4, 2024

Published on: 15 January, 2024

Page: [459 - 464] Pages: 6

DOI: 10.2174/0115733971272967231120114621

Price: $65

Abstract

Background and Aim: A tenosynovial giant cell tumor (TGCT) is a proliferative lesion of the synovial membrane of the joints, tendon sheaths and/or bursae. There are two described subtypes, including the localized and diffuse forms. A TGCT can also be intraarticular or extraarticular. An intraarticular localized tenosynovial giant cell tumor (L-TGCT) of the knee is characterized by nodular hyperplasic synovial tissue that can remain asymptomatic for a long time, but as the mass grows, it may cause mechanical symptoms that may require surgical treatment. The aim of our study is to present a rare case of an L-TGCT of the knee joint treated with an arthroscopic excision.

Case Report: We describe the case of a 17-year-old female with pain, swelling and knee locking in the absence of trauma. The magnetic resonance imaging (MRI) displayed a well-circumscribed small mass in the anterior medial compartment, adherent to the infrapatellar fat pad. The lesion presented the typical MRI characteristics of an intraarticular localized TGCT. The patient was treated with an arthroscopic mass removal and partial synovectomy. The gross pathology showed an ovoid nodule that was covered by a fibrous capsule; a histopathology examination confirmed the diagnosis. The patient was able to return to normal daily activities one month after surgery; at the three-year follow-up, she was free of symptoms with no evidence of disease on the MRI.

Conclusion: In patients with a small-dimension L-TGCT in the anterior compartment of the knee that presents an MRI pattern and causes mechanical symptoms, an arthroscopic en-bloc excision can be performed that results in good outcomes and a rapid return to preinjury levels.

[1]
Kim JH, Lee SK, Kim JY. Prediction of local recurrence in tenosynovial giant cell tumor of the knee: Based on preoperative MRI evaluation into disease subtypes and severity. PLoS One 2023; 18(6): e0287028.
[http://dx.doi.org/10.1371/journal.pone.0287028] [PMID: 37315053]
[2]
Gouin F, Noailles T. Localized and diffuse forms of tenosynovial giant cell tumor (formerly giant cell tumor of the tendon sheath and pigmented villonodular synovitis). Orthop Traumatol Surg Res 2017; 103(1): S91-7.
[http://dx.doi.org/10.1016/j.otsr.2016.11.002] [PMID: 28057477]
[3]
Mastboom MJL, Staals EL, Verspoor FGM, et al. Surgical treatment of localized-type tenosynovial giant cell tumors of large joints. J Bone Joint Surg Am 2019; 101(14): 1309-18.
[http://dx.doi.org/10.2106/JBJS.18.01147] [PMID: 31318811]
[4]
Bansal A, Goyal S, Goyal A, Jana M. WHO classification of soft tissue tumours 2020: An update and simplified approach for radiologists. Eur J Radiol 2021; 143: 109937.
[http://dx.doi.org/10.1016/j.ejrad.2021.109937] [PMID: 34547634]
[5]
Sharma P, Tiwari V, Khan SA, Rastogi S. An unusual case of Pigmented Villo-Nodular Synovitis of the second toe: A case report and review of literature. Foot 2016; 28: 61-3.
[http://dx.doi.org/10.1016/j.foot.2016.08.001] [PMID: 27720630]
[6]
Shewmaker C. Intra-articular focal nodular synovitis of the knee. J Orthop Sports Phys Ther 2017; 47(4): 293.
[http://dx.doi.org/10.2519/jospt.2017.7221] [PMID: 28363273]
[7]
Trompeter A, Servant C. An unusual cause of a patient presenting with an acutely locked knee: Multiple benign fat pad cysts. Arch Orthop Trauma Surg 2009; 129(8): 1123-5.
[http://dx.doi.org/10.1007/s00402-009-0838-4] [PMID: 19238410]
[8]
Kalinterakis G, Vlastos I, Gianzina E, Karvountzis A, Mastrantonakis K, Yiannakopoulos CK. Giant cell tumor of the patellar tendon sheath mimicking a meniscal tear in athletes. A report of two cases. J Orthop Case Rep 2022; 12(11): 54-9.
[http://dx.doi.org/10.13107/jocr.2022.v12.i11.3414] [PMID: 37013238]
[9]
Jandhyala R, Wilson A, Bhagat S, Lavelle J. An unusual cause of locking. Knee Surg Sports Traumatol Arthrosc 2007; 15(5): 682-4.
[http://dx.doi.org/10.1007/s00167-006-0184-9] [PMID: 16953398]
[10]
AlAqeel MA, Al-Ahaideb A. Synovial osteochondroma originating from the synovium of the anterior cruciate ligament. BMJ Case Rep 2013; 2013: bcr2012008218.
[http://dx.doi.org/10.1136/bcr-2012-008218] [PMID: 23345533]
[11]
Huri G, Biçer OS. Unusual cause of knee locking. Case Rep Orthop 2013; 2013: 1-3.
[http://dx.doi.org/10.1155/2013/837140] [PMID: 23476852]
[12]
Tu NV, Quyen NVS, Ngoc MH, Trung HP, Nguyen BS, Trung DT. Tenosynovial giant cell tumor of cruciate ligament: A case report and review. Int J Surg Case Rep 2022; 91: 106771.
[http://dx.doi.org/10.1016/j.ijscr.2022.106771] [PMID: 35091349]
[13]
Agarwala S, Agrawal P, Moonot P, Sobti A. A rare case of giant cell tumour arising from anterior cruciate ligament: Its diagnosis and management. J Clin Orthop Trauma 2015; 6(2): 140-3.
[http://dx.doi.org/10.1016/j.jcot.2014.12.005] [PMID: 25983523]
[14]
Jaffe HL, Lichtenstein L, Sutro CJ. Pigmented villonodular synovitis, bursitis, tenosynovitis. Arch Pathol (Chic) 1941; 31: 731-65.
[15]
Granowitz SP, D’Antonio J, Mankin HL. The pathogenesis and long-term end results of pigmented villonodular synovitis. Clin Orthop Relat Res 1976; (114): 335-51.
[PMID: 770040]
[16]
Spierenburg G, Suevos C, Stoel BC, et al. MRI of diffuse-type tenosynovial giant cell tumour in the knee: A guide for diagnosis and treatment response assessment. Insights Imaging 2023; 14(1): 22.
[http://dx.doi.org/10.1186/s13244-023-01367-z] [PMID: 36725759]
[17]
Ho J, Peters T, Dickson BC, et al. Detection of CSF1 rearrangements deleting the 3′ UTR in tenosynovial giant cell tumors. Genes Chromosomes Cancer 2020; 59(2): 96-105.
[http://dx.doi.org/10.1002/gcc.22807] [PMID: 31469468]
[18]
Yoo JH, Yang BK, Park JM. Localized nodular synovitis of the knee presenting as anterior knee pain: A case report. Knee 2007; 14(5): 398-401.
[http://dx.doi.org/10.1016/j.knee.2007.06.005] [PMID: 17662608]
[19]
Rhatomy S, Septiawan EM. Locked knee due to fat pad adhesion. Int J Surg Case Rep 2020; 77: 264-8.
[http://dx.doi.org/10.1016/j.ijscr.2020.10.115] [PMID: 33189008]
[20]
Özalay M, Tandoğan RN, Akpınar S, et al. Arthroscopic treatment of solitary benign intra-articular lesions of the knee that cause mechanical symptoms. Arthroscopy 2005; 21(1): 12-8.
[http://dx.doi.org/10.1016/j.arthro.2004.08.013] [PMID: 15650661]
[21]
Huang GS, Lee CH, Chan WP, Chen CY, Yu JS, Resnick D. Localized nodular synovitis of the knee: MR imaging appearance and clinical correlates in 21 patients. AJR Am J Roentgenol 2003; 181(2): 539-43.
[http://dx.doi.org/10.2214/ajr.181.2.1810539] [PMID: 12876042]
[22]
Zmerly H, Moscato M, Akkawi I. Assessment and management of loose bodies in the knee joint and related disease: A narrative review. Curr Rheumatol Rev 2022; 18(1): 12-9.
[http://dx.doi.org/10.2174/1573397117666211021165807] [PMID: 34674623]
[23]
Rudd A, Pathria MN. Intra-articular neoplasms and masslike lesions of the knee. Magn Reson Imaging Clin N Am 2022; 30(2): 339-50.
[http://dx.doi.org/10.1016/j.mric.2021.11.011] [PMID: 35512894]
[24]
Lausé GE, Baird MD, Krul KP, Bottoni CR. Tenosynovial giant-cell tumor presenting as septic arthritis of the knee. J Am Acad Orthop Surg Glob Res Rev 2021; 5(4): e00089.
[http://dx.doi.org/10.5435/JAAOSGlobal-D-20-00089] [PMID: 33830088]
[25]
Sullivan CJ, Eustace SJ, Kavanagh EC. Pigmented villonodular synovitis of the hip joint: Three cases demonstrating characteristic MRI features. Radiol Case Rep 2020; 15(8): 1335-8.
[http://dx.doi.org/10.1016/j.radcr.2020.05.067] [PMID: 32617126]
[26]
Papamerkouriou YM, Posantzis MI, Kouremenos D, Manousakis C, Plessas SI. Arthroscopic technique for the treatment of localized pigmented villonodular synovitis of the knee. Cureus 2020; 12(4): e7832.
[http://dx.doi.org/10.7759/cureus.7832] [PMID: 32467807]
[27]
Kubat O, Mahnik A, Smoljanović T, Bojanić I. Arthroscopic treatment of localized and diffuse pigmented villonodular synovitis of the knee. Coll Antropol 2010; 34(4): 1467-72.
[PMID: 21874741]
[28]
Daoud J, Aouad D, Hassan Y, El Rassi G. Localized pigmented villonodular synovitis of the posterior knee compartment with popliteal vessel compression: A case report of arthroscopic resection using only anterior knee portals. Case Rep Orthop 2018; 2018: 1-4.
[http://dx.doi.org/10.1155/2018/7532358] [PMID: 30034899]
[29]
Aurégan JC, Bohu Y, Lefevre N, et al. Primary arthroscopic synovectomy for pigmented villo-nodular synovitis of the knee: Recurrence rate and functional outcomes after a mean follow-up of seven years. Orthop Traumatol Surg Res 2013; 99(8): 937-43.
[http://dx.doi.org/10.1016/j.otsr.2013.08.004] [PMID: 24161841]
[30]
Poutoglidou F, Metaxiotis D, Mpeletsiotis A. Pigmented villonodular synovitis of the knee joint in a 10-year-old patient treated with an all-arthroscopic synovectomy: A case report. Cureus 2020; 12(12): e11929.
[http://dx.doi.org/10.7759/cureus.11929] [PMID: 33425510]
[31]
Stacchiotti S, Dürr HR, Schaefer IM, et al. Best clinical management of tenosynovial giant cell tumour (TGCT): A consensus paper from the community of experts. Cancer Treat Rev 2023; 112: 102491.
[http://dx.doi.org/10.1016/j.ctrv.2022.102491] [PMID: 36502615]
[32]
Chan AS, Katiyar V, Dy P, Singh V. Updates on the treatment of tenosynovial giant cell tumor (TGCT). Hematol Oncol Stem Cell Ther 2022; 16(4): 307-15.
[http://dx.doi.org/10.56875/2589-0646.1032] [PMID: 37363972]
[33]
Palmerini E, Longhi A, Donati DM, Staals EL. Pexidartinib for the treatment of adult patients with symptomatic tenosynovial giant cell tumor: Safety and efficacy. Expert Rev Anticancer Ther 2020; 20(6): 441-5.
[http://dx.doi.org/10.1080/14737140.2020.1757441] [PMID: 32297819]
[34]
Bernthal NM, Randall RL, Zeitlinger LN, Geiger EJ, Healey JH. Complementary effects of surgery and pexidartinib in the management of patients with complex diffuse-tenosynovial giant cell tumor. Case Rep Orthop 2022; 2022: 1-13.
[http://dx.doi.org/10.1155/2022/7768764] [PMID: 36510622]
[35]
Geiger EJ, Jensen AR, Singh AS, Nelson SD, Bernthal NM. Use of neoadjuvant pexidartinib with limb salvage surgery for diffuse tenosynovial giant cell tumor: A case report. J Orthop Sci 2022; 2658: 00304-9.
[http://dx.doi.org/10.1016/j.jos.2022.10.016]
[36]
Jain JK, Vidyasagar JVS, Sagar R, Patel H, Chetan ML, Bajaj A. Arthroscopic synovectomy in pigmented villonodular synovitis of the knee: Clinical series and outcome. Int Orthop 2013; 37(12): 2363-9.
[http://dx.doi.org/10.1007/s00264-013-2003-5] [PMID: 23860791]
[37]
Yoo HJ, Nam HS, Park SB, Lee YS. Effectiveness of arthroscopic excision based on the distribution of the tenosynovial giant cell tumor around knee joint. Knee 2023; 41: 360-72.
[http://dx.doi.org/10.1016/j.knee.2023.01.024] [PMID: 36848705]
[38]
Diri D, Alasaad H, Mhana SAA, Ibrahim J. A case report of arthroscopic treatment of a retro-patellar GCTTS causing anterior knee pain. Int J Surg Case Rep 2023; 105: 108089.
[http://dx.doi.org/10.1016/j.ijscr.2023.108089] [PMID: 37018943]
[39]
Yotsumoto T, Iwasa J, Uchio Y. Localized pigmented villonodular synovitis in the knee associated with locking symptoms. Knee 2008; 15(1): 68-70.
[http://dx.doi.org/10.1016/j.knee.2007.09.001] [PMID: 17945499]
[40]
Tedesco AJ, Tedesco NS. Monoarticular, multifocal, localized tenosynovial giant cell tumor of the knee. JBJS Case Connect 2020; 10(1): e0479.
[http://dx.doi.org/10.2106/JBJS.CC.19.00479] [PMID: 32044773]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy